MARISSA CITARELLI: Open Payments
NPI 1578188363 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,160 in 93 payments from 37 companies in 2025. Trend: 2023 $25 · 2024 $1,320 · 2025 $2,160
Food & beverage: $2,160
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $279 |
| PFIZER INC. | 9 | $217 |
| AstraZeneca Pharmaceuticals LP | 7 | $203 |
| Incyte Corporation | 5 | $120 |
| GENZYME CORPORATION | 4 | $114 |
| Genentech USA, Inc. | 4 | $109 |
| Merck Sharp & Dohme LLC | 4 | $98 |
| Janssen Biotech, Inc. | 5 | $88 |
| Ipsen Biopharmaceuticals, Inc | 3 | $80 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
Products named: IBRANCE, KISQALI, CARVYKTI, KEYTRUDA, PLUVICTO, ELREXFIO, Onivyde, LYNPARZA.
Industry payments across VA — which companies pay providers there.
